Infectious Disease Control APAC News & Press Release Distribution

Infectious Disease Control

All
Global

INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Vulvar Dysplasia Caused by HPV-16/18

- DNA immunotherapy candidate VGX-3100 demonstrated clinically significant reduction of HPV-16/18-associated precancerous vulvar lesions in 63% of treated participants six months after treatment - Phase 2 results indicate that VGX-3100 can be a safe, tolerable and efficacious adjunct to current ...

2021-01-06 21:00 3347

INOVIO and Advaccine Announce Exclusive Partnership To Commercialize COVID-19 DNA Vaccine Candidate, INO-4800, in Greater China

PLYMOUTH MEETING, Pa. and SUZHOU, China, Jan. 4, 2021 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, and Advaccine Biopharmaceuticals Suzhou Co., Ltd. ("A...

2021-01-04 21:00 4171

RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib

Preliminary data from the non-powered U.S. Phase 2 study of 40 hospitalized patients shows that orally-administered opaganib was safe, with no material safety differences between opaganib and control arms Consistent trends demonstrate greater improvement in reducing oxygen requirement by end of ...

2020-12-31 22:38 7547

INEX Innovate's CORO(TM) Real-Time RT-PCR SARS-CoV-2 Kit for the detection of COVID-19 obtains Singapore's Health Sciences Authority Provisional Authorisation

* The COVID-19 pandemic has seen in excess of 81 million confirmed cases globally and more than 1.7 million deaths and rising daily (1) * CORO™ Real-Time RT-PCR SARS-CoV-2 for the diagnosis of COVID-19, was developed based on three genes recommended by the World Health Organisation (WHO) * ...

2020-12-29 17:24 2177

INEX Innovate's CORO(TM) Real-Time RT-PCR SARS-CoV-2 Kit for the detection of COVID-19 obtains Singapore's Health Sciences Authority Provisional Authorisation

Universiti Teknologi Malaysia Community responded to COVID-19 threats through R&D

JOHOR BAHRU, Malaysia, Dec. 29, 2020 /PRNewswire/ -- Researchers from Universiti Teknologi Malaysia (UTM) have swung into action to respond to the threat posed by COVID-19 pandemic. Frugal innovations and inventions were developed to improve efficiency and quality in creating relevant and adaptab...

2020-12-29 10:00 2514

Universiti Teknologi Malaysia Community responded to COVID-19 threats through R&D

Thailand continues to reopen for travellers slowly and safely

BANGKOK, Dec. 23, 2020 /PRNewswire/ -- Thailand's tourism sector continues to safely and slowly reopen welcoming international travellers to the country with special tourist initiatives, while also remaining vigilant by enforcing strict public health guidelines to protect all during the ongoing C...

2020-12-23 15:53 2628

Thailand continues to reopen for travellers slowly and safely

Irish Technology deployed in South Africa as part of International Music Events re-opening

DUBLIN, Dec. 23, 2020 /PRNewswire/ -- Irish-based Health Passport Europe has partnered with Big Concerts and The Entertainment Group to safely re-open the events industry inSouth Africa, using latest developments in rapid COVID-19 testing and the secure Health Passport Europe mobile technology. ...

2020-12-23 03:15 3351

Irish Technology deployed in South Africa as part of International Music Events re-opening

RedHill's Phase 2/3 COVID-19 Study of Opaganib Passes Second DSMB with Unanimous Recommendation to Continue

Independent DSMB unanimously recommends continuation of the global Phase 2/3 study of orally-administered opaganib in severe COVID-19 based on review of unblinded safety data from 155 treated patients Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021 Top-line d...

2020-12-22 20:38 4204

BioVaxys Vaccine Platform Stimulates Robust T-cell Response Against Viral Antigens

VANCOUVER, British Columbia, Dec. 21, 2020 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB, OTC:LMNGF) ("BioVaxys") announced today that further analysis of the data from a preclinical animal study (also known as the "murine model study") of its haptenized viral protein vaccine tech...

2020-12-21 21:00 2028

Open Care announces Immubio platform based on nanoparticle science, currently developing potential break-through COVID-19 immunisation

MELBOURNE, Australia, Dec. 17, 2020 /PRNewswire/ -- Open Care (https://open.care ) have announced the progress of their early-stage development of their potential COVID-19 Immunisation, ImmubioCV, based on Nanobiologics, a new approach centered on nanoparticles, water coherent...

2020-12-17 20:52 1466

Open Care announces Immubio platform based on nanoparticle science, currently developing potential break-through COVID-19 immunisation

Future Uncertainty Hangs Heavy in Cigna COVID-19 Study

HONG KONG, Dec. 17, 2020 /PRNewswire/ -- Cigna's (NYSE:CI) International Markets business today published the fourth edition of itsCOVID-19 Global Impact Study , which reveals that people are increasingly w...

2020-12-17 13:01 6709

E-Tech's ALTANT Ozonized Alcohol Disinfectant Shown to Inactivate Both Novel Coronavirus and Swine Fever Virus, World's First

KOBE, Japan, Dec. 16, 2020 /PRNewswire/ -- Joint research between E-Tech Co., Ltd. and Obihiro University of Agriculture and Veterinary Medicine has verified the ability of ALTANT ozonized alcohol disinfectant to inactivate COVID-19. E-Tech's joint research withHokkaido University has also verif...

2020-12-16 15:00 1320

Senecio Robotics awarded US$12 Million from the European Commission to address mosquito borne diseases

TEL AVIV, Israel, Dec. 16, 2020 /PRNewswire/ -- With more than 2,000 early stage companies applying for the EU EIC Accelerator Pilot May cutoff,only 64 companies were selected

2020-12-16 08:01 1583

More than 10 million additional children under 5 will suffer from malnutrition in next two years due to COVID-19

Global leaders commit more than US$3 billion to address hunger and nutrition crisis OTTAWA, Ontario, Dec. 16, 2020 /PRNewswire/ -- The Governments of Canada and Bangladesh, in partnership with the Government of Japan, on Monday hosted a virtual launch of theNutrition for Growth Year of Action, s...

2020-12-16 07:55 1406

AIDA Cruises uses temperature detection by DERMALOG

ROSTOCK and HAMBURG, Germany, Dec. 15, 2020 /PRNewswire/ -- AIDA Cruises has implemented the contactless Body Temperature Camera from the German company DERMALOG as part of its health and hygiene concept. DERMALOG's solution measures body temperature in real-time using state-of-the-art sensor te...

2020-12-15 21:20 1622

Canadian pilot study suggests prescription icosapent ethyl (VASCEPA®) might improve symptoms of COVID-19 and reduce inflammation

TORONTO, ON, Dec. 14, 2020 /PRNewswire/ -- The results of a Canadian study released this weekend provides encouraging data suggesting that the prescription strength omega-3 called icosapent ethyl (VASCEPA) may reduce inflammation and improve symptoms in patients with a diagnosis of COVID-19. "Th...

2020-12-14 20:00 1787

China Life Singapore-special supported 'Love & Hope' Gala Concert to be dedicated to outstanding frontline workers

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- On December 13, 2020, the "Love & Hope" Gala Concert, organized by Huaxia Cultural Hub, was held in the Singapore Conference Hall, presenting a wonderful musical performance for locals. China Life Insurance (Singapore) Pte. Ltd. ("China Life Singapore")pro...

2020-12-14 14:44 2609

China Life Singapore-special supported 'Love & Hope' Gala Concert to be dedicated to outstanding frontline workers

NCH Asia Pacific calls for consistent maintenance and vigilance during this pandemic with the 'NCH Disinfection Program'

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- NCH Asia Pacific is a global leader in industrial and commercial maintenance products and services since 1919. The company was formed during the 1918 pandemic and harkens back to the time when we all beat the flu using disinfectants and by observing prop...

2020-12-14 09:00 1095

NCH Asia Pacific calls for consistent maintenance and vigilance during this pandemic with the 'NCH Disinfection Program'

2020-12-14 09:00 1950

Kintor Proxalutamide's COVID-19 Clinical Trial Shows Significant Reduction in Hospitalization and Ventilation Rates

SUZHOU, China, Dec. 12, 2020 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the Proxalutamide's clinical trial for the treatment of COVID-19. Proxalutamide is a new androgen receptor (AR) antagonist developed in by Kintor Pharmaceutica...

2020-12-12 11:02 12314

1 ... 30 31 323334 35 36 ... 65